BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9251027)

  • 21. Cell cycle. Confirmational change.
    Pines J
    Nature; 1995 Jul; 376(6538):294-5. PubMed ID: 7630391
    [No Abstract]   [Full Text] [Related]  

  • 22. Picture story. Cyclin switch.
    Riddihough G
    Nat Struct Biol; 1995 Aug; 2(8):636. PubMed ID: 7552724
    [No Abstract]   [Full Text] [Related]  

  • 23. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2.
    Gyuris J; Golemis E; Chertkov H; Brent R
    Cell; 1993 Nov; 75(4):791-803. PubMed ID: 8242750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.
    Yeh CT; Lu SC; Chen TC; Peng CY; Liaw YF
    Cancer Res; 2000 Sep; 60(17):4697-700. PubMed ID: 10987270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex.
    Russo AA; Jeffrey PD; Patten AK; Massagué J; Pavletich NP
    Nature; 1996 Jul; 382(6589):325-31. PubMed ID: 8684460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A predictive scale for evaluating cyclin-dependent kinase substrates. A comparison of p34cdc2 and p33cdk2.
    Holmes JK; Solomon MJ
    J Biol Chem; 1996 Oct; 271(41):25240-6. PubMed ID: 8810285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15.
    Sebastian B; Kakizuka A; Hunter T
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3521-4. PubMed ID: 8475101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.
    Kriwacki RW; Hengst L; Tennant L; Reed SI; Wright PE
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11504-9. PubMed ID: 8876165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro.
    Higashi H; Suzuki-Takahashi I; Taya Y; Segawa K; Nishimura S; Kitagawa M
    Biochem Biophys Res Commun; 1995 Nov; 216(2):520-5. PubMed ID: 7488142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells.
    Lawrie AM; Tito P; Hernandez H; Brown NR; Robinson CV; Endicott JA; Noble ME; Johnson LN
    Protein Expr Purif; 2001 Nov; 23(2):252-60. PubMed ID: 11676600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetic basis for activation of CDK2/cyclin A by phosphorylation.
    Hagopian JC; Kirtley MP; Stevenson LM; Gergis RM; Russo AA; Pavletich NP; Parsons SM; Lew J
    J Biol Chem; 2001 Jan; 276(1):275-80. PubMed ID: 11029468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thr-161 phosphorylation of monomeric Cdc2. Regulation by protein phosphatase 2C in Xenopus oocytes.
    De Smedt V; Poulhe R; Cayla X; Dessauge F; Karaiskou A; Jessus C; Ozon R
    J Biol Chem; 2002 Aug; 277(32):28592-600. PubMed ID: 12036957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclin-dependent kinases and cyclin-dependent kinase inhibitors. Detection methods and activity measurements.
    Brooks G
    Methods Mol Biol; 2001; 124():161-70. PubMed ID: 11100474
    [No Abstract]   [Full Text] [Related]  

  • 34. Human HTm4 is a hematopoietic cell cycle regulator.
    Donato JL; Ko J; Kutok JL; Cheng T; Shirakawa T; Mao XQ; Beach D; Scadden DT; Sayegh MH; Adra CN
    J Clin Invest; 2002 Jan; 109(1):51-8. PubMed ID: 11781350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cell cycle inhibitor p21CIP is phosphorylated by cyclin A-CDK2 complexes.
    Jaumot M; Estañol JM; Casanovas O; Graña X; Agell N; Bachs O
    Biochem Biophys Res Commun; 1997 Dec; 241(2):434-8. PubMed ID: 9425288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bound to activate: conformational consequences of cyclin binding to CDK2.
    Radzio-Andzelm E; Lew J; Taylor S
    Structure; 1995 Nov; 3(11):1135-41. PubMed ID: 8591024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2.
    Poon RY; Yamashita K; Adamczewski JP; Hunt T; Shuttleworth J
    EMBO J; 1993 Aug; 12(8):3123-32. PubMed ID: 8393783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. K252a inhibits the phosphorylation of pRb without changing the levels of G1 cyclins and Cdk2 protein in human hepatoma cells.
    Nakayama T; Hashimoto Y; Kaneko Y; Kurokawa K
    Biochem Biophys Res Commun; 1996 Jul; 224(1):180-3. PubMed ID: 8694809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
    Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
    Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.